{"id":919278,"date":"2025-12-12T10:33:03","date_gmt":"2025-12-12T15:33:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/"},"modified":"2025-12-12T10:33:03","modified_gmt":"2025-12-12T15:33:03","slug":"intelligent-bio-solutions-inc-announces-reverse-stock-split-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/","title":{"rendered":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split"},"content":{"rendered":"
\n

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc.\u00a0(Nasdaq: INBS) (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d),\u00a0a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective\u00a0at 11:59 pm (Eastern Time) on December 15, 2025. Trading of the Company’s common stock on The Nasdaq Capital Market (\u201cNasdaq\u201d) will continue, on a split-adjusted basis, with the opening of the markets on\u00a0December 16, 2025, under the trading symbol \u201cINBS\u201d and new CUSIP number 36151G709.<\/p>\n

The reverse stock split was approved by Intelligent Bio Solutions\u2019 stockholders at the annual meeting of the Company\u2019s stockholders held on October 16, 2025, with the final ratio to be determined by the Company\u2019s Board of Directors within the ratio range authorized by shareholders.<\/p>\n

As a result of the reverse stock split, every 10 shares of common stock issued and outstanding as of the effective date will be automatically combined into one share of common stock. \u00a0In addition, proportionate adjustments will be made to outstanding equity-based awards and other equity rights, including warrants. No fractional shares will be issued if, as a result of the reverse stock split, a stockholder would become entitled to a fractional share because the number of shares of common stock they hold before the reverse stock split is not evenly divisible by the split ratio. Instead, the stockholder will be entitled to receive a cash payment in lieu of a fractional share. The par value of the common stock will remain unchanged at $0.01 per share after the reverse split, and the number of authorized shares of common stock will remain at 100 million shares. Immediately after the reverse stock split becomes effective, the Company will have approximately 959,533 shares of common stock issued and outstanding. The reverse split affects all stockholders uniformly and will not alter any stockholder\u2019s percentage interest in the Company\u2019s equity, except to the extent the reverse split results in a stockholder receiving a cash payment in lieu of a fractional share, as described above.<\/p>\n

\n About Intelligent Bio Solutions Inc.<\/strong>\n <\/p>\n

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its\u00a0Intelligent Fingerprinting Drug Screening System\u00a0will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company\u2019s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.<\/p>\n

For more information, visit:\u00a0https:\/\/ibs.inc\/<\/u><\/a><\/p>\n

\n Forward-Looking Statements:<\/strong>\n <\/p>\n

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, and involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, statements regarding Intelligent Bio Solutions Inc.\u2019s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefits from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, actual results may differ materially from those expressed or implied by such statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including \u201cbelieves,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cprojects,\u201d \u201cintends,\u201d \u201cpotential,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201capproximately\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those described in Intelligent Bio Solutions\u2019 public filings with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of the date of this release. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.<\/p>\n

\n Company Contact:\u00a0<\/strong>
\n
Intelligent Bio Solutions Inc.\u00a0
info@ibs.inc<\/u><\/a>\u00a0
LinkedIn<\/u><\/a>\u00a0|\u00a0Twitter<\/u><\/a><\/p>\n

\n Investor & Media Contact:\u202f<\/strong>
\n
Valter Pinto, Managing Director\u202f\u202f\u202f\u00a0
KCSA Strategic Communications\u202f\u202f\u202f\u00a0
PH: (212) 896-1254\u202f\u202f\u202f\u00a0
INBS@kcsa.com<\/a> \u202f\u202f\u00a0\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc.\u00a0(Nasdaq: INBS) (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d),\u00a0a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective\u00a0at 11:59 pm (Eastern Time) on December 15, 2025. Trading of the Company’s common stock on The Nasdaq Capital Market (\u201cNasdaq\u201d) will continue, on a split-adjusted basis, with the opening of the markets on\u00a0December 16, 2025, under the trading symbol \u201cINBS\u201d and new CUSIP number 36151G709. The reverse stock split was approved by Intelligent Bio Solutions\u2019 stockholders at the annual meeting of the Company\u2019s stockholders held on October 16, 2025, with the final ratio to … <\/p>\n

Continue reading “Intelligent Bio Solutions Inc. Announces Reverse Stock Split”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-919278","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIntelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc.\u00a0(Nasdaq: INBS) (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d),\u00a0a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective\u00a0at 11:59 pm (Eastern Time) on December 15, 2025. Trading of the Company’s common stock on The Nasdaq Capital Market (\u201cNasdaq\u201d) will continue, on a split-adjusted basis, with the opening of the markets on\u00a0December 16, 2025, under the trading symbol \u201cINBS\u201d and new CUSIP number 36151G709. The reverse stock split was approved by Intelligent Bio Solutions\u2019 stockholders at the annual meeting of the Company\u2019s stockholders held on October 16, 2025, with the final ratio to … Continue reading "Intelligent Bio Solutions Inc. Announces Reverse Stock Split"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-12T15:33:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Intelligent Bio Solutions Inc. Announces Reverse Stock Split\",\"datePublished\":\"2025-12-12T15:33:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/\"},\"wordCount\":749,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/\",\"name\":\"Intelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=\",\"datePublished\":\"2025-12-12T15:33:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intelligent Bio Solutions Inc. Announces Reverse Stock Split\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/","og_locale":"en_US","og_type":"article","og_title":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk","og_description":"NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc.\u00a0(Nasdaq: INBS) (\u201cIntelligent Bio Solutions\u201d or the \u201cCompany\u201d),\u00a0a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective\u00a0at 11:59 pm (Eastern Time) on December 15, 2025. Trading of the Company’s common stock on The Nasdaq Capital Market (\u201cNasdaq\u201d) will continue, on a split-adjusted basis, with the opening of the markets on\u00a0December 16, 2025, under the trading symbol \u201cINBS\u201d and new CUSIP number 36151G709. The reverse stock split was approved by Intelligent Bio Solutions\u2019 stockholders at the annual meeting of the Company\u2019s stockholders held on October 16, 2025, with the final ratio to … Continue reading \"Intelligent Bio Solutions Inc. Announces Reverse Stock Split\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-12T15:33:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split","datePublished":"2025-12-12T15:33:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/"},"wordCount":749,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/","name":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=","datePublished":"2025-12-12T15:33:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMTQzMyM3MzE3NTg4IzIxODk1NjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intelligent-bio-solutions-inc-announces-reverse-stock-split-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=919278"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919278\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=919278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=919278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=919278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}